Our Vision
Chlovelxy was born out of unbearable personal suffering.
Years ago, our founder was diagnosed with severe progressive rheumatoid arthritis, often called “the incurable cancer of joints” in medical circles.
The disease advanced rapidly. Uncontrolled inflammation destroyed joint tissue, caused leg tissue necrosis, and eventually left his legs completely paralyzed. He lost all ability to stand, walk or move his lower body. Day and night, he lived with constant, overwhelming joint pain.
He tried everything available: prescription medicine, hormone therapy, painful injections, physical rehabilitation, plus dozens of popular joint creams and patches. None worked well. Traditional topical products were greasy, stained clothing, and only delivered temporary cooling feelings. They could not reach deep tissue to ease persistent soreness.
Refusing to spend his life trapped in paralysis, bedridden, he devoted himself to formula research. Through thousands of failed lab trials, he created Chlovelxy’s unique film‑forming active‑ingredient gel.
This lightweight gel dries rapidly and forms a breathable protective layer on skin. It will not rub off or stick to fabrics, while steadily releasing active compounds to soothe joint discomfort. For the first time in years, he experienced real relief.
Chlovelxy is not built for profit first. It is built from personal agony. We understand what it means to be crippled, helpless and limited by joint disease. Our vision is simple: spare millions of other people from the same pain our founder endured.
We believe reliable joint wellness support should be accessible globally. We keep improving formulas, focus on science‑backed ingredients, and refuse to cut corners on safety. Our goal: help people regain comfortable, free‑moving daily lives.
Elena Marlow
Founder & Research Lead
